By Thomas Insel on June 12, 2012
Dr. Insel discusses the crisis of medication development for mental disorders.
Continue reading “Experimental Medicine”…
By Thomas Insel on January 26, 2012
Dr. Insel responds to discussion from the National Advisory Mental Health Council concerning the need to balance research funding for basic science and mental health services.
Continue reading “Balancing Immediate Needs with Future Innovation”…
By Thomas Insel on January 05, 2012
Dr. Insel discusses opportunities for treatment development.
Continue reading “Treatment Development: Where do we go from here?”…
By Thomas Insel on December 23, 2011
Dr. Insel shares NIMH’s Top 10 Research Advances for 2011.
Continue reading “NIMH’s Top 10 Research Advances of 2011”…
By Thomas Insel on December 22, 2011
Dr. Insel discusses opportunities for treatment development.
Continue reading “Treatment Development: Where do we go from here?”…
By Thomas Insel on December 14, 2011
Dr. Insel discusses the state of psychiatric research and development (R&D) in the public and private sectors
Continue reading “Treatment Development: The Past 50 Years”…
By Thomas Insel on December 06, 2011
Dr. Insel discusses the complicated nature of research on the efficacy antidepressants.
Continue reading “Antidepressants: A complicated picture”…
By Thomas Insel on December 23, 2010
10 breakthroughs and events of 2010 which are changing the way we approach mental disorders.
Continue reading “NIMH’s Top 10 Research Events and Advances of 2010”…
By Thomas Insel on December 01, 2010
NIMH/NIH is nurturing medications development via assays that probe new molecular targets relevant to mental disorders.
The National Institute of Mental Health (NIMH) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services.
NIH…Turning Discovery Into Health®
This page last reviewed: December 15, 2011.
